Litigation Details for Astellas Pharma Inc. v. Aurobindo Pharma Limited (D. Del. 2018)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Aurobindo Pharma Limited (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-06-25 |
Court | District Court, D. Delaware | Date Terminated | 2018-09-24 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,017,927 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Astellas Pharma Inc. v. Aurobindo Pharma Limited
Details for Astellas Pharma Inc. v. Aurobindo Pharma Limited (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-09-24 | 13 | relating to United States Patent No. 6,017,927 ("the '927 patent"); …certification with respect to the '927 patent to a Paragraph III certification pursuant to which…which it agrees that the '927 patent, plus any other exclusivity, will expire before the…earlier than the expiration date of the '927 patent, including any extensions and/or additional…III certification with respect to the '927 patent, the parties have resolved this action; | External link to document | |
2018-09-24 | 14 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,017,927. (Attachments: # 1 … 24 September 2018 1:18-cv-00932 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
2018-06-25 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,017,927. (crb) (Entered: 06… 24 September 2018 1:18-cv-00932 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |